OSUR
ORASURE TECHNOLOGIES INC
$4.15
+2.72%
$285.7M
No data for this timeframe.
Vol
Market Cap$285.7M
Cap SizeMicro Cap
Inst. Holders7 funds
Inst. Value$20.4M
Inst. Activity1 buys / 1 sells
Insider Activity7B / 0S
Insider Net $$546.0K
Reddit Sentiment33° Cool
SEC Reports12
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001116463·Prev Close $4.04
Recent Activity
Jun 3, 2026
SEC
OraSure Technologies held its 2026 Annual Meeting on June 3, 2026. Stockholders approved an amendment to the Stock Award
8-K — Impact 3/10
Jun 3, 2026
Insider
McMahon Robert W. sold 46,106 shares
Director @ $0.00 ($0.00)
Jun 3, 2026
Insider
Marmora Lelio sold 46,106 shares
Director @ $0.00 ($0.00)
Jun 3, 2026
Insider
Gagliano Nancy J sold 46,106 shares
Director @ $0.00 ($0.00)
May 6, 2026
SEC
OraSure reported Q1 2026 revenue of $27.9M, down 7% YoY, and a GAAP EPS loss of $0.32, wider than the prior year's $0.21
8-K — Impact 6/10
Apr 22, 2026
SEC
OraSure Technologies announced a Q4 2025 earnings miss with EPS of $-0.27, significantly below consensus of $-0.17, repr
PRESS-RELEASE — Impact 7/10
Inst.
MORGAN STANLEY — ADD
529,262 shares ($1.3M)
Inst.
TWO SIGMA INVESTMENTS, LP — EXIT
0 shares ($0.00)
Price Targets
Historical data — last covering-analyst action Nov 2025. No current recommendation available.
$4.75 (Nov 2025)
Current $4.24
Low $3.50
Median $4.75
High $6.00
2 analysts
$3.50
$6.00
Analyst Ratings
3Strong Buy
3Buy
2Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Nov 12, 2025 | Stephens & Co. | MAINTAIN | Equal-Weight → Equal-Weight |
| May 19, 2025 | Evercore ISI Group | MAINTAIN | In-Line → In-Line |
| May 8, 2025 | Evercore ISI Group | MAINTAIN | In-Line → In-Line |
| Aug 7, 2024 | Evercore ISI Group | MAINTAIN | In-Line → In-Line |
| Jul 2, 2024 | Evercore ISI Group | MAINTAIN | In-Line → In-Line |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.18 ▼ -26.6% | $-0.22 — $-0.14 | 6% YoY | 2 |
| Next Q | $-0.15 ▼ -7.5% | $-0.20 — $-0.09 | -13% YoY | 2 |
| Current FY | $-0.70 ▼ -24.7% | $-0.84 — $-0.56 | -1% YoY | 2 |
| Next FY | $-0.50 ▼ -7.1% | $-0.63 — $-0.38 | 28% YoY | 2 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $9.9M | — |
| RENAISSANCE TECHNOLOGIES LLC | $5.2M | — |
| WELLS FARGO & COMPANY/MN | $2.1M | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $1.5M | NEW |
| MORGAN STANLEY | $1.3M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 3, 2026 | McMahon Robert | A | $0.00 |
| Jun 3, 2026 | Marmora Lelio | A | $0.00 |
| Jun 3, 2026 | Gagliano Nancy | A | $0.00 |
| Jun 3, 2026 | Kenny John | A | $0.00 |
| Jun 3, 2026 | Bertrand John | A | $0.00 |
Reddit Sentiment
33°
Cool
Bearish
Neutral
Bullish
7 institutional holders with $20.4M total value (8,419,350 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, WELLS.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 4,102,632 | $9.9M | 48.7% | — |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 2,145,003 | $5.2M | 25.5% | — |
| 3 | WELLS FARGO & COMPANY/MN | 877,030 | $2.1M | 10.4% | — |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 622,083 | $1.5M | 7.4% | NEW |
| 5 | MORGAN STANLEY | 529,262 | $1.3M | 6.3% | ADD +63.5% |
| 6 | BANK OF AMERICA CORP /DE/ | 132,429 | $320.5K | 1.6% | TRIM -26.1% |
| 7 | FMR LLC | 10,911 | $26.4K | 0.1% | TRIM -30.1% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 323,658 | 529,262 | +63.5% | $1.3M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 43,300 | 0 | -100.0% | $0.00 | 2025-Q4 |
| UBS Group AG | ADD | 364,504 | 722,520 | +98.2% | $2.3M | 2025-Q3 |
| MORGAN STANLEY | TRIM | 672,156 | 323,658 | -51.8% | $1.0M | 2025-Q3 |
| UBS Group AG | TRIM | 564,629 | 364,504 | -35.4% | $1.1M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | TRIM | 175,310 | 129,480 | -26.1% | $388.4K | 2025-Q2 |
| FMR LLC | TRIM | 15,350 | 10,729 | -30.1% | $32.2K | 2025-Q2 |
| UBS Group AG | TRIM | 1,561,018 | 564,629 | -63.8% | $1.9M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 153,029 | 48,723 | -68.2% | $164.2K | 2025-Q1 |
| CAUSEWAY CAPITAL MANAGEMENT LLC | EXIT | 10,092 | 0 | -100.0% | $0.00 | 2025-Q1 |
| UBS Group AG | DOUBLED | 32,017 | 1,561,018 | +4775.6% | $5.6M | 2024-Q4 |
| CAUSEWAY CAPITAL MANAGEMENT LLC | NEW | — | 10,092 | — | $36.4K | 2024-Q4 |
| MORGAN STANLEY | TRIM | 1,239,883 | 926,465 | -25.3% | $4.0M | 2024-Q3 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 694,634 | — | $3.0M | 2024-Q3 |
9 unique insiders with 7 transactions. Net insider value: $546.0K ($546.0K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | McMahon Robert W. | Director | A | 46,106 | $0.00 | $0.00 |
| Jun 3, 2026 | Marmora Lelio | Director | A | 46,106 | $0.00 | $0.00 |
| Jun 3, 2026 | Gagliano Nancy J | Director | A | 46,106 | $0.00 | $0.00 |
| Jun 3, 2026 | Kenny John P. | Director | A | 46,106 | $0.00 | $0.00 |
| Jun 3, 2026 | Bertrand John D. | Director | A | 46,106 | $0.00 | $0.00 |
| Jun 3, 2026 | Boyd Steven Kyle | Director | A | 46,106 | $0.00 | $0.00 |
| May 14, 2026 | Boyd Steven Kyle | Director | BUY | 25,000 | $2.99 | $74.8K |
| May 13, 2026 | Gagliano Nancy J | Director | F | 21,305 | $3.02 | $64.3K |
| May 13, 2026 | McMahon Robert W. | Director | F | 22,888 | $3.02 | $69.1K |
| May 13, 2026 | Marmora Lelio | Director | F | 28,406 | $3.02 | $85.8K |
| May 13, 2026 | Boyd Steven Kyle | Director | BUY | 25,000 | $3.02 | $75.5K |
| May 12, 2026 | Bertrand John D. | Director | A | 33,661 | $0.00 | $0.00 |
| May 12, 2026 | Boyd Steven Kyle | Director | BUY | 25,000 | $2.98 | $74.5K |
| Mar 26, 2026 | Boyd Steven Kyle | Director | A | 5,246 | $3.10 | $16.2K |
| Mar 26, 2026 | Boyd Steven Kyle | Director | F | 1,416 | $3.10 | $4.4K |
| Mar 20, 2026 | EGLINTON MANNER CARRIE | President & CEO | BUY | 32,300 | $2.93 | $94.6K |
| Mar 20, 2026 | McGrath Kenneth J | Chief Financial Officer | BUY | 32,300 | $2.93 | $94.6K |
| Mar 13, 2026 | McGrath Kenneth J | Chief Financial Officer | BUY | 22,021 | $3.00 | $66.0K |
| Mar 13, 2026 | EGLINTON MANNER CARRIE | President & CEO | BUY | 22,022 | $3.00 | $66.0K |
| Mar 2, 2026 | EGLINTON MANNER CARRIE | President & CEO | A | 355,464 | $0.00 | $0.00 |
| Mar 2, 2026 | McGrath Kenneth J | Chief Financial Officer | A | 88,348 | $0.00 | $0.00 |
| Mar 2, 2026 | Anthony Michele Marie | SVP Finance & CAO | A | 42,982 | $0.00 | $0.00 |
| Mar 1, 2026 | McGrath Kenneth J | Chief Financial Officer | A | 26,814 | $0.00 | $0.00 |
| Mar 1, 2026 | EGLINTON MANNER CARRIE | President & CEO | A | 129,032 | $0.00 | $0.00 |
| Mar 1, 2026 | Anthony Michele Marie | SVP Finance & CAO | A | 14,183 | $0.00 | $0.00 |
| Mar 1, 2026 | Anthony Michele Marie | SVP Finance & CAO | F | 4,062 | $3.04 | $12.4K |
12 SEC filing reports analyzed. Sentiment: 4 bullish, 2 bearish, 2 mixed, 4 neutral. Avg impact: 5.4/10.
NEUTRAL
8-K
3/10
OraSure Technologies held its 2026 Annual Meeting on June 3, 2026. Stockholders approved an amendmen
Jun 3, 2026
BEARISH
8-K
6/10
OraSure reported Q1 2026 revenue of $27.9M, down 7% YoY, and a GAAP EPS loss of $0.32, wider than th
May 6, 2026
BEARISH
PRESS-RELEASE
7/10
OraSure Technologies announced a Q4 2025 earnings miss with EPS of $-0.27, significantly below conse
Apr 22, 2026
BULLISH
DEFA14A
7/10
OraSure Technologies has filed definitive proxy materials following a recently announced cooperation
Apr 17, 2026
BULLISH
DEFA14A
7/10
OraSure Technologies has resolved a proxy contest with activist investor Altai Capital by appointing
Apr 17, 2026
NEUTRAL
8-K
5/10
OraSure Technologies has entered into a cooperation agreement with activist investor Altai Capital,
Apr 17, 2026
NEUTRAL
CLUSTER
2/10
Analysis based on filing metadata only — document content was unavailable. This insider trading clus
Mar 30, 2026
BULLISH
CLUSTER
6/10
OraSure Technologies' CEO and CFO each purchased approximately 32,300 shares in the open market at a
Mar 23, 2026
MIXED
DEFA14A
6/10
OraSure Technologies filed a definitive proxy statement (DEFA14A) in response to an activist campaig
Mar 17, 2026
BULLISH
CLUSTER
7/10
OraSure Technologies CFO Kenneth McGrath and CEO Carrie Eginton Manner each purchased approximately
Mar 17, 2026
NEUTRAL
8-K
3/10
David J. Shulkin, M.D. resigned from his position as a director and member of the Compensation Commi
Mar 5, 2026
MIXED
8-K
6/10
OraSure Technologies reported a significant decline in Q4 and full-year 2025 revenue, down 29% and 3
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Nov 2025): 75% buy across 8 analysts — 3 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Nov 2025. No current recommendation available.
$4.75 mean target (Nov 2025)
$3.50 Low
$6.00 High
| Metric | Value |
|---|---|
| Current Price | $4.24 |
| Target Low | $3.50 |
| Target Mean | $4.75 |
| Target Median | $4.75 |
| Target High | $6.00 |
| # Analysts | 2 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.18 | $-0.22 | $-0.14 | 5.9% | -26.6% | 0↑ 2↓ | $0.0B | -7.7% | 2 |
| Next Q 2026-09-30 |
$-0.15 | $-0.20 | $-0.09 | -12.6% | -7.5% | 1↑ 0↓ | $0.0B | 14.0% | 2 |
| Current FY 2026-12-31 |
$-0.70 | $-0.84 | $-0.56 | -1.3% | -24.7% | 0↑ 2↓ | $0.1B | 4.1% | 2 |
| Next FY 2027-12-31 |
$-0.50 | $-0.63 | $-0.38 | 28.0% | -7.1% | 0↑ 2↓ | $0.1B | 6.8% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.179 | |
| 7d ago | $-0.142 | -0.037 |
| 30d ago | $-0.141 | -0.038 |
| 60d ago | $-0.141 | -0.038 |
| 90d ago | $-0.139 | -0.039 |
11 analyst firms have rated this stock: 4 upgrades, 8 downgrades, 8 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Nov 12, 2025 | Stephens & Co. | MAINTAIN | Equal-Weight | Equal-Weight |
| May 19, 2025 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| May 8, 2025 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Aug 7, 2024 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Jul 2, 2024 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| May 13, 2024 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Apr 4, 2024 | Evercore ISI Group | MAINTAIN | In-Line | In-Line |
| Feb 29, 2024 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Dec 11, 2023 | Citigroup | MAINTAIN | Buy | Buy |
| Nov 8, 2023 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Jul 17, 2023 | Stephens & Co. | MAINTAIN | Equal-Weight | Equal-Weight |
| May 11, 2022 | Citigroup | MAINTAIN | — | Buy |
| Feb 24, 2022 | Citigroup | MAINTAIN | — | Buy |
| Sep 22, 2021 | Raymond James | DOWNGRADE | Outperform | Market Perform |
| Aug 4, 2021 | Raymond James | MAINTAIN | — | Outperform |
| Jun 28, 2021 | Raymond James | MAINTAIN | — | Outperform |
| May 6, 2021 | Raymond James | MAINTAIN | — | Outperform |
| Aug 21, 2020 | Evercore ISI Group | INITIATE | — | Outperform |
| Aug 10, 2020 | JP Morgan | INITIATE | — | Neutral |
| Aug 10, 2020 | Citigroup | INITIATE | — | Buy |
| Aug 7, 2020 | Raymond James | UPGRADE | Market Perform | Outperform |
| May 9, 2019 | Canaccord Genuity | DOWNGRADE | Buy | Hold |
| Jul 16, 2018 | Stephens & Co. | DOWNGRADE | Overweight | Equal-Weight |
| Nov 2, 2017 | Jefferies | DOWNGRADE | Buy | Hold |
| Aug 3, 2017 | Canaccord Genuity | MAINTAIN | — | Buy |
| Feb 9, 2017 | Raymond James | UPGRADE | Market Perform | Outperform |
| Dec 21, 2016 | CL King | INITIATE | — | Buy |
| Sep 19, 2016 | BTIG | DOWNGRADE | Buy | Neutral |
| Aug 29, 2016 | Stephens & Co. | UPGRADE | Equal-Weight | Overweight |
| Aug 24, 2016 | Canaccord Genuity | MAINTAIN | — | Buy |
| Aug 4, 2016 | Jefferies | MAINTAIN | — | Buy |
| Jun 13, 2016 | Raymond James | DOWNGRADE | Outperform | Market Perform |
| Nov 11, 2015 | Canaccord Genuity | MAINTAIN | — | Buy |
| Jun 17, 2015 | Jefferies | MAINTAIN | — | Buy |
| May 7, 2015 | Jefferies | MAINTAIN | — | Buy |
| May 7, 2015 | JMP Securities | DOWNGRADE | Market Outperform | Market Perform |
| Dec 31, 2014 | Jefferies | MAINTAIN | — | Buy |
| Oct 16, 2014 | Canaccord Genuity | MAINTAIN | — | Buy |
| Jun 12, 2014 | Jefferies | MAINTAIN | — | Buy |
| Jun 12, 2014 | Canaccord Genuity | MAINTAIN | — | Buy |
| May 8, 2014 | Raymond James | MAINTAIN | — | Outperform |
| Nov 7, 2013 | Stephens & Co. | DOWNGRADE | Overweight | Equal-Weight |
| Jul 16, 2013 | Cowen & Co. | UPGRADE | Market Perform | Outperform |
| May 31, 2013 | Jefferies | MAINTAIN | — | Buy |
| May 31, 2013 | Jefferies | INITIATE | — | Buy |
| Mar 28, 2013 | Stephens & Co. | INITIATE | — | Overweight |
| Feb 7, 2013 | Jefferies | MAINTAIN | — | Buy |
| Nov 8, 2012 | Jefferies | MAINTAIN | — | Buy |
| Oct 15, 2012 | Raymond James | INITIATE | — | Market Perform |
| Oct 2, 2012 | Cowen & Co. | INITIATE | — | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 3 | 2 | 0 | 0 | 75% | |
| May 1, 2026 | 3 | 3 | 2 | 0 | 0 | 75% | |
| Apr 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| Mar 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| Feb 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% | |
| Jan 1, 2026 | 3 | 3 | 3 | 0 | 0 | 67% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
33°
Cool
Bearish
Neutral
Bullish
2 mentions
0 bullish
2 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 27, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 27, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
Recent Reddit Threads
OraSure Technologies (OSUR) & screening for Ebola
▲ 1
💬 1
⚡ 0.5
Cheap calendar on $OSUR
▲ 1
💬 0
⚡ 0.5
May 6, 2026
earnings_calendar
OSUR Q1 2026 Earnings Scheduled — 2026-05-06
Apr 22, 2026
earnings
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
<p>BETHLEHEM, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call c
Apr 17, 2026
other
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
Mar 17, 2026
other
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
Feb 25, 2026
earnings_calendar
OSUR Q4 2025 Earnings After Market Close — 2026-02-25